Development and Evaluation of a Prediabetes Decision Aid in Primary Care: Examining Patient-Reported Outcomes by Language Preference and Educational Attainment

Abstract

Purpose

The purpose of this study was to examine the development and preliminary effectiveness of a novel Prediabetes Decision Aid on adoption of intensive lifestyle interventions (ILIs) and metformin. Little research has focused on increasing uptake of these evidence-based treatments, especially among non-English speakers and those with low educational attainment.

Methods

Investigators developed an English and Spanish decision aid displaying information about type 2 diabetes (T2DM) risk and treatments to prevent T2DM and prompting patients to identify next steps for management. This pilot study was a single-arm, pretest-posttest trial of 40 adult patients with prediabetes, obesity, and ≥1 office visit within the prior 12 months. Participants reviewed this tool briefly with a study team member, and data were collected on 3 coprimary outcomes: knowledge about T2DM risk, decisional conflict, and intention to adopt treatment. Exploratory outcomes included subsequent documentation of prediabetes in chart notes and adoption of ILIs or metformin.

Results

Almost all participants were women, with nearly half expressing Spanish language preference and low educational attainment. A nonsignificant increase in knowledge was observed across all subgroups. Decisional conflict was significantly reduced from pretest to posttest and was similar between subgroups defined by language preference and educational attainment. While intention to adopt ILIs increased across all subgroups, this change was only significant among Spanish speakers and participants with low educational attainment. At 6 months, 17 participants had subsequent provider documentation of prediabetes, and 12 adopted ILIs or metformin.

Conclusions

The decision aid improved patient-reported outcomes and promoted treatment adoption in a diverse patient sample.

Get full access to this article

View all access options for this article.

References

Nathan

Davidson

DeFronzo

, et al. Impaired fasting glucose and impaired glucose tolerance implications for care. Diabetes Care. 2007;30(3):753-759.

Gerstein

Santaguida

Raina

, et al. Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies. Diabetes Res Clin Pract. 2007;78(3):305-312.

Centers for Disease Control and Prevention. National Diabetes Statistics Report 2020. CDC; 2020.

Diabetes Prevention Program Research Group. Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study. Lancet Diabetes Endocrinol. 2015;3(11):866-875.

Tseng

Yeh

Maruthur

. Metformin use in prediabetes among U.S. adults, 2005-2012. Diabetes Care. 2017;40(7):887-893.

Gruss

Nhim

Gregg

Bell

Luman

Albright

. Public health approaches to type 2 diabetes prevention: the US National Diabetes Prevention Program and beyond. Curr Diab Rep. 2019;19(9):78.

Moin

Duru

, et al. Metformin prescription for insured adults with prediabetes from 2010 to 2012: a retrospective cohort study. Ann Intern Med. 2015;162(8):542-548.

O’Brien

Whitaker

Ackermann

. The comparative efficacy of lifestyle intervention and metformin by educational attainment in the Diabetes Prevention Program. Prev Med. 2015;77:125-130.

Ritchie

Christoe-Frazier

McFann

Havranek

Pereira

. Effect of the National Diabetes Prevention Program on weight loss for English- and Spanish-speaking Latinos. Am J Health Promot. 2018;32(3):812-815.

10.

American Diabetes Association. Standards of medical care in diabetes-2015 abridged for primary care providers. Clin Diabetes. 2015;33(2):97-111.

11.

Centers for Disease Control and Prevention. Awareness of prediabetes–United States, 2005-2010. MMWR Morb Mortal Wkly Rep. 2013;62(11):209.

12.

Troughton

Jarvis

Skinner

Robertson

Khunti

Davies

. Waiting for diabetes: perceptions of people with pre-diabetes: a qualitative study. Patient Educ Couns. 2008;72(1):88-93.

13.

Rosal

Borg

Bodenlos

Tellez

Ockene

. Awareness of diabetes risk factors and prevention strategies among a sample of low-income Latinos with no known diagnosis of diabetes. Diabetes Educ. 2011;37(1):47-55.

14.

Salmela

Vahasarja

Villberg

, et al. Perceiving need for lifestyle counseling: findings from Finnish individuals at high risk of type 2 diabetes. Diabetes Care. 2012;35(2):239-241.

15.

Nhim

Khan

Gruss

, et al. Primary care providers’ prediabetes screening, testing, and referral behaviors. Am J Prev Med. 2018;55(2):e39-e47.

16.

O’Brien

Lee

Carnethon

, et al. Detecting dysglycemia using the 2015 United States Preventive Services Task Force screening criteria: a cohort analysis of community health center patients. PLoS Med. 2016;13(7):e1002074.

17.

Kandula

Moran

Tang

O’Brien

. Preventing diabetes in primary care: providers’ perspectives about diagnosing and treating prediabetes. Clin Diabetes. 2018;36(1):59-66.

18.

O’Connor

Bennett

Stacey

, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2009;(3):CD001431.

19.

Stacey

Légaré

Col

, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2014;1(1):CD001431.

20.

O’Connor

Legare

Stacey

. Risk communication in practice: the contribution of decision aids. BMJ. 2003;327(7417):736-740.

21.

Ottawa Hospital Research Institute. Patient decision aids. The Ottawa Hospital. 2019. Accessed July 31, 2020. https://decision aid.ohri.ca/index.html

22.

Moin

Duru

Turk

, et al. Effectiveness of shared decision-making for diabetes prevention: 12-month results from the Prediabetes Informed Decision and Education (PRIDE) Trial.J Gen Intern Med. 2019;34(11):2652-2659.

23.

Knowler

Barrett-Connor

Fowler

, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393-403.

24.

Elwyn

O’Connor

Stacey

, et al. Developing a quality criteria framework for patient decision aids: online international Delphi consensus process. BMJ. 2006;333(7565):417.

25.

O’Connor

Tugwell

Wells

, et al. A decision aid for women considering hormone therapy after menopause: decision support framework and evaluation. Patient Educ Couns. 1998;33(3):267-279.

26.

O’Connor

Jacobsen

. Workbook on Developing and Evaluating Patient Decision Aids. Ottawa Health Research Institute; 2003.

27.

International Patient Decision Aid Standards. International patient decision aid standards collaboration. 2013. Accessed July 31, 2020. http://ipdas.ohri.ca/

28.

Williams

Rodin

Ryan

Grolnick

Deci

. Autonomous regulation and long-term medication adherence in adult outpatients. Health Psychol. 1998;17(3):269-276.

29.

Williams

Grow

Freedman

Ryan

Deci

. Motivational predictors of weight loss and weight-loss maintenance. J Pers Soc Psychol. 1996;70(1):115-126.

30.

Williams

McGregor

Zeldman

Freedman

Deci

. Testing a self-determination theory process model for promoting glycemic control through diabetes self-management. Health Psychol. 2004;23(1):58-66.

31.

Akbar

Anderson

Gallegos

. Predicting intentions and behaviours in populations with or at-risk of diabetes: a systematic review. Prev Med Rep. 2015;2:270-282.

32.

Montaño

Kasprzyk

. Theory of reasoned action, theory of planned behavior, and the integrated behavioral model. In: Glanz

Rimer

Viswanath

, eds. Health Behavior and Health Education: Theory, Research, and Practice. Jossey-Bass Inc Pub; 2008:95-124.

33.

University of Michigan Center for Health Communications Research. Visualizing health. University of Michigan and the Robert Wood Johnson Foundation. 2014. Accessed July 31, 2020. http://www.vizhealth.org/gallery/

34.

Centers for Disease Control and Prevention. Plain language materials & resources. US Department of Health & Human Services. 2016. Accessed July 31, 2020. https://www.cdc.gov/healthliter acy/developmaterials/plainlanguage.html

35.

O’Brien

Cameron

Vargas

, et al. Evaluation of a prediabetes decision aid on patient-reported outcomes in primary care: a pilot study. J Gen Intern Med. 2021;36(3):824-826.

36.

American Diabetes Association. Standards of medical care in diabetes—2020. Diabetes Care. 2020;43(suppl 1):S1-S2.

37.

Walker

Caban

Schechter

, et al. Measuring comparative risk perceptions in an urban minority population: the risk perception survey for diabetes. Diabetes Educ. 2007;33(1):103-110.

38.

O’Connor

. Validation of a decisional conflict scale. Med Decis Making. 1995;15(1):25-30.

39.

O’Connor

. User manual–measures of decision/choice predisposition. Ottawa Hospital Research Institute. 1996. Updated 2003. Accessed July 31, 2020. https://decisionaid.ohri.ca/docs/develop/User_Manuals/UM_ChoicePredisposition_Decision.pdf

40.

Cheng

Kanaya

Araneta

MRG

, et al. Prevalence of diabetes by race and ethnicity in the United States, 2011-2016. JAMA. 2019;322(24):2389-2398.

41.

Agardh

Allebeck

Hallqvist

Moradi

Sidorchuk

. Type 2 diabetes incidence and socio-economic position: a systematic review and meta-analysis. Int J Epidemiol. 2011;40(3):804-818.

42.

Stonbraker

Schnall

Larson

. Tools to measure health literacy among Spanish speakers: an integrative review of the literature. Patient Educ Couns. Published online July 21, 2015. doi:10.1016/j.pec.2015.07.012

43.

Richardson

Allen

Xiao

Vallone

. Effects of race/ethnicity and socioeconomic status on health information-seeking, confidence, and trust. J Health Care Poor Underserved. 2012;23(4):1477-1493.

44.

Careyva

Shaak

Burgess

, et al. Designing and evaluating a prediabetes shared decision aid. J Am Board Fam Med. 2020;33(2):262-270.

45.

Mullan

Montori

Shah

, et al. The diabetes mellitus medication choice decision aid: a randomized trial. Arch Intern Med. 2009;169(17):1560-1568.

46.

Denig

Schuling

Haaijer-Ruskamp

Voorham

. Effects of a patient oriented decision aid for prioritising treatment goals in diabetes: pragmatic randomised controlled trial. BMJ. 2014;349:g5651.

47.

Sundaram

Ayala

Greenlund

Keenan

. Differences in the prevalence of self-reported risk factors for coronary heart disease among American women by race/ethnicity and age: behavioral risk factor surveillance system, 2001. Am J Prev Med. 2005;29(5 suppl 1):25-30.

48.

Knops

Goossens

Ubbink

Legemate

Stalpers

Bossuyt

. Interpreting patient decisional conflict scores: behavior and emotions in decisions about treatment. Med Decis Making. 2013;33(1):78-84.

49.

Hivert

Warner

Shrader

Grant

Meigs

. Diabetes risk perception and intention to adopt healthy lifestyles among primary care patients. Diabetes Care. 2009;32(10):1820-1822.

50.

Pinelli

Herman

Brown

Jaber

. Perceived risk and the willingness to enroll in a diabetes prevention lifestyle intervention in Arab-Americans. Diabetes Res Clin Pract. 2010;90(2):e27-e29.

51.

YMCA’s Diabetes Prevention Program. Diabetes Prevention Program FACT SHEET: January 2018. YMCA of the USA; 2018.

52.

Haire-Joshu

Hill-Briggs

. The next generation of diabetes translation: a path to health equity. Annu Rev Public Health. 2019;40:391-410.

53.

Carey

Bekemeier

Campos-Outcalt

Koch-Weser

Millon-Underwood

Teutsch

. National institutes of health pathways to prevention workshop: achieving health equity in preventive services. Ann Intern Med. 2020;172(4): 272-278.